Triadelta Partners Ltd. is SME dedicated to discovery and development of innovative solutions for the management of human health disorders, primarily in areas of infectious and inflammatory diseases. The company has been established in early 2013, and built around extensive international senior management experience of its founders in biotech, medium, large and multinational publicly listed companies. Triadelta Partners have deep understanding of global pharmaceutical industry trends and successful track record in setting up corporate strategies and leading strategic transformations that arise from successful history in leading top class international life sciences R&D teams and organizations.
Extensive expertise in drug discovery, translational science and early clinical development in therapeutic areas infection, inflammation and oncology is combined with experience in various areas of the business including R&D, business development, M&A activities, strategic alliances and investor relationships, as well as medical affairs and marketing.
Specific areas include Business development and funding solutions for R&D projects and organizations, R&D consultancy for drugs and medical devices, and R&D management and services.